Activated Carbon Tablets/Capsules 250 Mg Each Tender - 151223373

Procurement Summary

Country: Ukraine

Summary: Activated Carbon Tablets/Capsules 250 Mg Each, Ammonia, Solution for External Use, 10%, 100 Ml Each, Metamizole Sodium, Solution for Injection, 500 Mg/Ml, 2 Ml, Validol Tablets 60 Mg Each, Ibuprofen...

Deadline: 23 Oct 2026

Posting Date: 21 Oct 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 151223373

Document Ref. No.: UA-2026-10-19-011387-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 100000

CPV Classification

33600000 - Pharmaceutical products
33610000 - Medicinal products for the alimentary tract and metabolism
33660000 - Medicinal products for the nervous system and sensory organs
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33630000 - Medicinal products for dermatology and the musculo-skeletal system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Activated charcoal tablets/capsules 250 mg, Ammonia, solution for external use, 10%, 100 ml each, Metamizole sodium, solution for injection, 500 mg/ml, 2 ml, Validol tablets 60 mg each, Ibuprofen, oral suspension, 100 mg/5 ml, 100 ml each, Diamond green solution for external use, alcohol 1%, 20 ml, Dexamethasone, solution for injection 4 mg/ml, Diclofenac solution for injection 25 mg/ml, Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each, Drotaverin solution for injection 20 mg/ml, 2 ml each in an ampoule, Dexketoprofen solution for injection 25 mg/ ml of 2 ml, Iodine, solution for external use application, 5%, 20 ml each, Captopril/hydrochlorothiazide, tablets, 50/12.5 mg each, Captopril, tablets, 25 mg each, Barbiturates in combination (ethyl ether of a-bromosovaleric acid 20 mg, phenobarbital 18.26 mg, peppermint oil 1.42 mg) oral drops of 25 ml, Caffeine-benzoate sodium, solution for injection, 100 mg/ml, 1 ml each, Loperamide tablets/capsules 2 mg each, Loratadine tablets 10 mg each, Corglycon solution for injection, 0.6 mg/ml, 1 ml each, Ketorolac solution for injection, 30 mg/ml, 1 ml each, Magnesium sulfate, solution for injection, 250 mg/ml, each 10 ml, Metoclopramide, solution for injections, 5 mg/ml, 2 ml each, Sodium chloride, solution for injection, 9 mg/ml, 5 ml each, Sodium chloride, solution for infusion, 9 mg/ml 200 ml, Nitroglycerin, sublingual tablets, 0.5 mg each, Procaine solution for injection 5 mg/ml in ampoule 2 ml, Paracetamol tablets/capsules 500 mg, Piracetam, solution for injection, 200 mg/ml, 5 ml each, Papav...
Edition purchases: goods Classifier and its corresponding code: DC 021:2015: 33600000-6 — Pharmaceutical products, ,, ,, ,, ,, ,, ,, Classification according to ATX: N05CB02, Classification according to INN: Barbiturates in combination with other drugs, Release form: Oral drops, Volume: 25 milliliters, Packaging type: Bottle, Ethyl ether of alpha-bromosovaleric acid: 20 mg, Phenobarbital: 18.26 mg, Peppermint oil: 1.42 mg,, ,, ,, ,, ,, ,, Paracetamol tablets/capsules 500 mg,, ,, ,, ,, Chlorhexidine, solution for external use 0.05% 200 ml,, ,, ,, ,, Ethamsylate solution for injection, 125 mg/ml by 2 ml,, ,, , NameClassifier and its corresponding codeQuantity/Units of measurementPlace of deliveryDate of deliveryName
DK 021:2015: 33600000-6 — Pharmaceutical products, ,, ,, ,, ,, ,, ,, Classification according to ATX: N05CB02, Classification according to INN: Barbiturates in combination with other drugs, Release form: Oral drops, Volume: 25 milliliters, Packaging type: Vial, Alpha-bromosovaleric acid ethyl ether: 20 mg, Phenobarbital: 18.26 mg, Peppermint oil: 1.42 mg,, ,, ,, ,, ,, , Paracetamol tablets/capsules 500 mg,, ,, ,, ,, Chlorhexidine, solution for external use 0.05% per 200 ml,, ,, ,, ,, Ethamsylate solution for injection, 125 mg/ml per 2 ml,, ,, , NameClassifier and its corresponding codeQuantity/Units of measurementPlace of deliveryDate suppliesNazva

Documents

 Tender Notice